Vaidya Sane Ayurved Laboratories Approves Acquisition of Parasnath Healthcare and Releases FY 2026 Financial Results

Vaidya Sane Ayurved Laboratories Approves Acquisition of Parasnath Healthcare and Releases FY 2026 Financial Results​

Vaidya Sane Ayurved Laboratories Limited announced key strategic decisions and approved its financial results for the fiscal year ending March 31, 2026. The Board of Directors held a meeting on May 15, 2026, and took several material actions, including the proposed acquisition of Parasnath Healthcare (OPC) Private Limited and the formalization of a subsidiary relationship.

The Company's Board approved the audited Annual Standalone and Consolidated Financial Results and Statements for the half year and the full year ended March 31, 2026, accompanied by a declaration of Unmodified opinion from the statutory auditors.

Major Strategic Transactions​

The Board noted and approved the proposed acquisition of Parasnath Healthcare (OPC) Private Limited. The acquisition involves securing 100% shareholding and/or acquiring the business undertaking through a structure to be determined.

The target entity, Parasnath Healthcare (OPC) Private Limited, is a company incorporated under the laws of India and is primarily engaged in operating and managing speciality healthcare related knee pain and clinic-related services, including franchisee clinic operations.

The proposed acquisition is expected to achieve strategic business expansion, consolidation of franchisee clinic operations, and strengthening the Company's presence in the healthcare and speciality clinic segment. The acquisition is expected to enable centralized management and improved operational efficiency. The consideration for the acquisition is stated as an approximate cash consideration of INR 6,00,00,000/- (Rupees Six Crores Only).

Furthermore, the Board noted that Aaharshastra Foodz Private Limited, which is currently a Wholly Owned Subsidiary, is undergoing the process of becoming a Subsidiary Company, subject to the completion of necessary formalities.

Auditor and Committee Appointments​

The Board also approved critical appointments for the financial year 2026-27:

• Secretarial Auditor: M/s. Deep Shukla & Associates, Practicing Company Secretary, Mumbai, was appointed as the Secretarial Auditor.
• Internal Auditor: M/s. Khare Deshmukh & Co., Chartered Accountants, Pune, was appointed as the Internal Auditor.

Financial Highlights​

The Company released comparative financial data for the full year and half year periods, comparing the fiscal year 2026 to 2025. The consolidated financial statements provide an overview of the performance across multiple periods.

The consolidated profit for the year ended March 31, 2026, was 898.66 Lakhs, compared to 713.61 Lakhs in the previous year.

The detailed financial performance for the full year period ended March 31, 2026, saw the Company report a Total Income of 10,927.41 Lakhs, driven by Revenue from Operations of 10,690.64 Lakhs. Total Expenses reached 9,846.85 Lakhs, resulting in a profit before tax of 1,080.56 Lakhs.

The key financial metrics are summarized below:

Consolidated Financial Performance (Amounts in INR Lakhs):


The total assets for the Group stood at 10,450.72 Lakhs as of March 31, 2026, compared to 7,895.92 Lakhs in the previous year.

Audit and Statutory Review​

The Company’s financials also provided a detailed statement of the utilization of funds raised through the preferential issue of Convertible Share Warrants. The Board reviewed the details confirming the purpose of the issuance, which was to augment funding needs for the general corporate purpose, working capital, and capital expenditure for building and developing new hospital premises at Kondhali.

The consolidated financial statements were presented with an Unmodified Opinion by the auditors, confirming the Group's true and fair view in accordance with generally accepted accounting principles.

Dr. Rohit Sane, Managing Director and Chief Executive Officer, and other directors, including Vidyut Ghag, Narendra Pawar, and Sapna Vaishnav, signed the official corporate statements, marking the completion of the statutory annual filings for the period.

MADHAVBAUG Stock Price Movement​

On Friday, shares of Vaidya Sane Ayurved Laboratories Limited edged higher, settling at ₹254.60 and recording a gain of 0.18%. Trading volume reached 2,400 shares, indicating moderate activity for the stock during the session.